Reply to comments on "evaluation of dabigatran exposures reported to poison centers"

Ann Pharmacother. 2014 May;48(5):664-5. doi: 10.1177/1060028014526161. Epub 2014 Feb 28.

Authors

Donald L Harrison¹, Scott E Schaeffer, Susan E Conway

Affiliation

¹ The University of Oklahoma College of Pharmacy, Oklahoma City, OK, USA.

PMID: 24586058
DOI: 10.1177/1060028014526161

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants / adverse effects*
Benzimidazoles / adverse effects*
Dabigatran
Female
Humans
Male
Poison Control Centers*
beta-Alanine / adverse effects
beta-Alanine / analogs & derivatives*

Substances

Anticoagulants
Benzimidazoles
beta-Alanine
Dabigatran